🔎 Trials Near Me

Почетна › Карцином ендометријума › Њу Џерзи

Kliničke studije za Карцином ендометријума u državi Њу Џерзи

32 studija za Карцином ендометријума traži učesnike na lokacijama u državi Њу Џерзи.

Gradovi u državi Њу Џерзи

Zvanični tekst studije (na engleskom)

A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors

  • START New Jersey, East Brunswick
  • Rutgers Cancer Institute of New Jersey, New Brunswick
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT06270706

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

  • Hunterdon Medical Center, Flemington
  • Monmouth Medical Center Southern Campus, Lakewood
  • Cooperman Barnabas Medical Center, Livingston
  • и још 6
Тражи се учесникФаза 2
Сви узрасти · Оба пола · Ажурирано 12. 11. 2026. · NCT05564377

Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER

  • Sidney Kimmel Cancer Center Washington Township, Sewell
Тражи се учесникФаза 2
Узраст 18 и старији · Жене · Ажурирано 12. 11. 2026. · NCT05640999

A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)

  • Holy Name Medical Center ( Site 6011), Teaneck
Тражи се учесникФаза 3
Узраст 18 и старији · Жене · Ажурирано 10. 11. 2026. · NCT06952504

A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types

  • START New Jersey, East Brunswick
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 10. 11. 2026. · NCT07503808

Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer

  • Memorial Sloan Kettering Basking Ridge, Basking Ridge
  • Cooper Hospital University Medical Center, Camden
  • Cooperman Barnabas Medical Center, Livingston
  • и још 7
Тражи се учесникФаза 3
Узраст 18 и старији · Жене · Ажурирано 6. 11. 2026. · NCT07198074

A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors

  • John Theurer Cancer Center at Hackensack UMC, Hackensack
Тражи се учесникФаза 1
Узраст 19 и старији · Оба пола · Ажурирано 5. 11. 2026. · NCT06586957

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

  • MD Anderson Cancer Center at Cooper- Two Cooper Plaza, Camden
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT05579366

Study of Induction PD-1 Blockade in Subjects With Locally Advanced Mismatch Repair Deficient Solid Tumors

  • Memorial Sloan Kettering Basking Ridge - Limited Protocol Activities, Basking Ridge
  • Memorial Sloan Kettering Monmouth - Limited Protocol Activities, Middletown
  • Memorial Sloan Kettering Bergen - Limited Protocol Activities, Montvale
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT04165772

Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer

  • Morristown Medical Center, Morristown
  • Atlantic Health - Overlook MC, Summit
  • Holy Name Medical Center, Teaneck
Тражи се учесникФаза 3
Узраст 18 и старији · Жене · Ажурирано 3. 11. 2026. · NCT07166094

EIK1005-002: A Clinical Research Study Evaluating EIK1005, a Werner Helicase Inhibitor, as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors Including Microsatellite Instability High (MSI-H) Tumors

  • Morristown Medical Center, Morristown
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 30. 10. 2026. · NCT07262619

A Phase 1 Study of LNCB74 in Advanced Solid Tumors

  • John Theurer Cancer Ctr at Hackensack Univ. Med Ctr., Hackensack
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 29. 10. 2026. · NCT06774963

A Study of Mutant Selective-Inhibitor (CGT6297), in Patients With Advanced Solid Tumors

  • START New Jersey, LLC, East Brunswick
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 22. 10. 2026. · NCT07383506

Radiation and TSR-042 (Dostarlimab) in People With Endometrial Cancer After They Receive Surgery

  • Memorial Sloan Kettering Basking Ridge (All Protocol Activites), Basking Ridge
  • Memorial Sloan Kettering Monmouth (All Protocol Activities), Middletown
  • Memorial Sloan Kettering Bergen (All Protocol Activities), Montvale
Тражи се учесникФаза 2
Узраст 18 и старији · Жене · Ажурирано 15. 10. 2026. · NCT04774419

Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors

  • START - New Jersey, East Brunswick
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 13. 10. 2026. · NCT06293898

DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer

  • Research Site, Hackensack
Тражи се учесникФаза 3
Узраст 18 и старији · Жене · Ажурирано 13. 10. 2026. · NCT06989112

Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors

  • The John Theurer Cancer Center at Hackensack University Medical Center, Hackensack
Тражи се учесникФаза 1
Узраст 15 и старији · Оба пола · Ажурирано 9. 10. 2026. · NCT06276491

ctDNA Testing to Inform Standard-of-Care Treatment Decisions in People With Endometrial Cancer

  • Memorial Sloan Kettering Basking Ridge (All Protocol Activites), Basking Ridge
  • Memorial Sloan Kettering Monmouth (All Protocol Activities), Middletown
  • Memorial Sloan Kettering Bergen (All Protocol Activities), Montvale
Тражи се учесник
Узраст 18 и старији · Жене · Ажурирано 25. 9. 2026. · NCT07270666

Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)

  • Research Site, East Brunswick
Тражи се учесникФаза 2
Узраст од 18 до 130 · Оба пола · Ажурирано 23. 9. 2026. · NCT05489211

A Study of Ivonescimab in People With Endometrial and Cervical Cancers

  • Memorial Sloan Kettering Basking Ridge (All Protocol Activities), Basking Ridge
  • Memorial Sloan Kettering Monmouth (All Protocol Activities), Middletown
  • Memorial Sloan Kettering Bergen (All Protocol Activities), Montvale
Тражи се учесникФаза 2
Узраст 18 и старији · Жене · Ажурирано 21. 9. 2026. · NCT06925724

PROton Therapy for Post Surgical Treatment of GYNecologic Cancer

  • Virtua Health, Voorhees Township
Тражи се учесникФаза 2
Узраст 18 и старији · Жене · Ажурирано 17. 9. 2026. · NCT05758688

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

  • Astera Cancer Care, East Brunswick
Тражи се учесникОпсервациона студија
Узраст 18 и старији · Оба пола · Ажурирано 14. 9. 2026. · NCT05059444

A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma

  • John Theurer Cancer Center at Hackensack University Medical Center, Hackensack
  • Rutgers Cancer Institute of NJ, New Brunswick
Тражи се учесникФаза 2
Узраст 18 и старији · Жене · Ажурирано 21. 8. 2026. · NCT05548296

A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors

  • Normunity Investigational Site, Hackensack
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 18. 8. 2026. · NCT07182149

Observational Study of Women With Endometrial Cancer Who Receive the Standard Treatment for Their Disease

  • Memorial Sloan Kettering Basking Ridge (All protocol activities), Basking Ridge
  • Memorial Sloan Kettering Monmouth (All protocol activities), Middletown
  • Memorial Sloan Kettering Bergen (All protocol activities), Montvale
Тражи се учесникОпсервациона студија
Узраст 18 и старији · Жене · Ажурирано 7. 8. 2026. · NCT04291612

Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors

  • Hackensack University Medical Center - John Theurer Cancer Center, Hackensack
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 5. 8. 2026. · NCT07444814

Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)

  • Research Site, Camden
  • Research Site, Paramus
Тражи се учесникФаза 3
Узраст 18 и старији · Жене · Ажурирано 29. 7. 2026. · NCT07044336

A Study of Elacestrant Alone or in Combination With Abemaciclib in People With Endometrial Cancer

  • Memorial Sloan Kettering Basking Ridge, Basking Ridge
  • Memorial Sloan Kettering Monmouth, Middletown
  • Memorial Sloan Kettering Bergen, Montvale
Тражи се учесникФаза 2
Узраст 18 и старији · Жене · Ажурирано 16. 7. 2026. · NCT07209449

Adaptive Daily MR-Guided Adjuvant Pelvic Therapy-Endometrial Cancer

  • Rutgers Cancer Institut Jersey, New Brunswick
Тражи се учесник
Узраст од 18 до 90 · Жене · Ажурирано 6. 7. 2026. · NCT07643012

A Study of Short-Course Radiation Therapy With Chemotherapy in People With Endometrial Cancer

  • Memorial Sloan Kettering Basking Ridge (All protocol activities), Basking Ridge
  • Memorial Sloan Kettering Monmouth (All protocol activities), Middletown
  • Memorial Sloan Kettering Bergen (All protocol activities), Montvale
Тражи се учесникРана фаза 1
Узраст 18 и старији · Жене · Ажурирано 25. 6. 2026. · NCT05691010

A Study of Multiparametric Ultrasound Imaging (mpUS) for People With Endometrial Cancer

  • Memorial Sloan Kettering at Basking Ridge (Consent Only), Basking Ridge
  • Memorial Sloan Kettering Monmouth (Consent Only), Middletown
  • Memorial Sloan Kettering Bergen (Consent Only), Montvale
Тражи се учесник
Узраст 18 и старији · Жене · Ажурирано 6. 1. 2026. · NCT07318415

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

  • Massive Bio SYNERGY-AI site, New Brunswick
Тражи се учесникОпсервациона студија
Сви узрасти · Оба пола · Ажурирано 28. 10. 2025. · NCT03452774

Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.